Basic Information
LncRNA/CircRNA Name | GAS5 |
Synonyms | NA |
Region | GRCh38_1:173863900-173868882 |
Ensemble | ENSG00000234741 |
Refseq | NR_002578 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | apoptosis | Drug | ||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | triple negative breast cancer |
ICD-0-3 | C50 |
Methods | qPCR, Western blot, Luciferase reporter assay |
Sample | triple negative breast cancer tissues, cell lines (MCF-7, T47D, BT474, MDA-MB-231 and MDA-MB-468) |
Expression Pattern | down-regulated |
Function Description | Levels of the lncRNA, growth arrest-specific transcript 5 (GAS5), are decreased in TNBC tissues, and this down-regulation of GAS5 is associated with an aggressive tumor phenotype in patients, affecting clinical stage, lymph node metastasis and overall survival. Using an ectopic overexpression system in TNBC cells, we found that up-regulation of GAS5 can significantly attenuate proliferation and enhance apoptosis in TNBC cells. Through bioinformatics analysis and verification with qRT-PCR and luciferase assay, we found that GAS5 can bind to miR-196a-5p and there is a negative relationship between GAS5 and miR-196a-5p expression among TNBC patient samples. Furthermore, we demonstrated that overexpression of GAS5 can partially undermine the tumor promotion effect induced by ectopic expression of miR-196a-5p, including invasion and downstream FOXO1/PI3K/AKT signal pathway activation. |
Pubmed ID | 29793177 |
Year | 2018 |
Title | Long Noncoding RNA GAS5 Suppresses Triple Negative Breast Cancer Progression Through Inhibition of Proliferation and Invasion by Competitively Binding miR-196a-5p |
External Links
Links for GAS5 | GenBank HGNC NONCODE |
Links for triple negative breast cancer | OMIM COSMIC |